Clinical Trial Update: Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating gefitinib followed by surgery for ductal carcinoma in situ of the breast was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ of the Breast

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED